AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Rituximab in South Africa
9 products registered with SAHPRA — 9 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| RIXATHON 500 mg/50 ml | 55/26/0406 | Sandoz South Africa (Pty) Ltd | active | 12 Mar 2029 |
| RIXATHON 100 mg/10 ml | 55/26/0405 | Sandoz South Africa (Pty) Ltd | active | 12 Mar 2029 |
| MABTHERA SC 1400 mg | 49/30.1/0466 | Roche Products (Pty) Ltd | active | 26 Jun 2024 |
| MABTHERA 500 | 32/26/0579 | Roche Products (Pty) Ltd | active | 1 Jan 1900 |
| RISTOVA 100 | 46/26/0868 | Roche Products (Pty) Ltd | active | 1 Jan 1900 |
| BLITZIMA 500 mg | 53/26/0507 | Adcock Ingram Limited | active | 1 Jan 1900 |
| RISTOVA 500 | 46/26/0869 | Roche Products (Pty) Ltd | active | 1 Jan 1900 |
| BLITZIMA 100 mg | 53/26/0506 | Adcock Ingram Limited | active | 1 Jan 1900 |
| MABTHERA 100 | 32/26/0578 | Roche Products (Pty) Ltd | active | 1 Jan 1900 |
Rituximab — SAHPRA Registration Details
SAHPRA (South Africa) has 9 registered products containing Rituximab, of which 9 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Rituximab registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.